| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 09/22/2004 | EP1458392A2 Acridone inhibitors of impdh enzyme |
| 09/22/2004 | EP1458382A1 Amide derivatives as gk activators |
| 09/22/2004 | EP1458381A1 Triazoles as oxytocin antagonists |
| 09/22/2004 | EP1458380A1 Cis-2,4,5- triphenyl-imidazolines and their use in the treatment of tumors |
| 09/22/2004 | EP1458379A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 09/22/2004 | EP1458376A1 Darifenacin for use in the treatment of urgency induced by overactive bladder |
| 09/22/2004 | EP1458375A2 Compositions for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1458374A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1169320B1 Farnesyl transferase inhibitors having a pyrrole structure and process for preparation thereof |
| 09/22/2004 | EP1144402B1 Substituted oximes and hydrazones as neurokinin antagonists |
| 09/22/2004 | EP1100781B1 High affinity ligands for nociceptin receptor orl-1 |
| 09/22/2004 | EP1054869B1 3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors |
| 09/22/2004 | EP1030841B1 Process for the preparation of 1,4-dihydropyridines and compounds used in this process |
| 09/22/2004 | CN1531527A Carbazole derivatives and their use as neuropeptide Y5 receptor ligands |
| 09/22/2004 | CN1167700C Triazole derivative possessing anti-fungus activity |
| 09/22/2004 | CN1167698C New N-triazolyl methyl piperazine derivative using as neurokinin receptor antagonistic agent |
| 09/22/2004 | CN1167697C Benzopyran derivative |
| 09/22/2004 | CN1167687C Arylpyridazinones as prostaglandin endoperoxide H synthase biosynthesis inhibitors |
| 09/22/2004 | CN1167686C Novel benzimidazole derivatives and pharmaceutical compsns. comprising these compounds |
| 09/22/2004 | CN1167682C Muscarinic antagonists |
| 09/22/2004 | CN1167680C Fused-ring compounds and use thereof as drugs |
| 09/22/2004 | CN1167422C Quinazoline derivatives as angiogenesis inhibitors |
| 09/21/2004 | US6794523 Anticancer agents, antitumor agents; leukemia |
| 09/21/2004 | US6794511 An enzyme inhibitors of metalloprotease; treating connective tissue degradation caused by inflammation or tumor |
| 09/21/2004 | US6794507 Compounds that inhibit factor Xa activity |
| 09/21/2004 | US6794406 For therapy and prophylaxis of arteriosclerosis and hypercholesterolaemia |
| 09/21/2004 | US6794404 Viral polymerase inhibitors |
| 09/21/2004 | US6794397 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/21/2004 | US6794393 Tyrosine kinase inhibitors |
| 09/21/2004 | US6794392 Cell differentiation inducer |
| 09/21/2004 | US6794386 β-amino acid compounds as integrin antagonists |
| 09/21/2004 | US6794381 Succinoylamino lactams as inhibitors of aβ protein |
| 09/21/2004 | US6794379 Antiinflammatory agents; autoimmune disease; skin disorders |
| 09/21/2004 | US6794372 Nitrate salts of antimicrobial agents |
| 09/21/2004 | US6794336 Herbicidal substituted pyridines, their preparation, and their use as herbicides and plant growth regulators |
| 09/21/2004 | CA2116973C Improved process for the synthesis of (5r)-1,1-dimethylethyl 6-cyano-5-hydroxy-3-oxo-hexanoate |
| 09/21/2004 | CA2114017C Amide tetrazole acat inhibitors |
| 09/21/2004 | CA2100381C N-derivatives of (phenylethyl-.beta.-ol) amine, a process for their preparation and pharmaceutical compositions containing the same |
| 09/21/2004 | CA2033143C Alkyl esters of 5-heterocyclic-pyridine-2,3-dicarboxylate acids, 5-heterocyclic 2-(2-imidazoline-2-yl)pyridines, useful as herbicidal agents and methods for the preparation thereof |
| 09/16/2004 | WO2004078875A2 Novel dyes and use thereof in imaging members and methods |
| 09/16/2004 | WO2004078874A2 Novel dye complexes and use thereof in imaging members and methods |
| 09/16/2004 | WO2004078851A1 Novel dyes and use thereof in thermal imaging members and methods |
| 09/16/2004 | WO2004078752A1 Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 09/16/2004 | WO2004078751A1 Benzofuran derivative |
| 09/16/2004 | WO2004078750A1 Tetrahydropyran compounds as tachykinin antagonists |
| 09/16/2004 | WO2004078748A2 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders |
| 09/16/2004 | WO2004078747A1 Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders |
| 09/16/2004 | WO2004078745A1 Biaryltetrahydroisoquinoline piperidines as selective mch receptor antagonists for the treatment of obesity and related disorders |
| 09/16/2004 | WO2004078733A1 Quinazolines useful as modulators of ion channels |
| 09/16/2004 | WO2004078732A1 N-aryl heteroaromatic products, compositions containing same and use thereof |
| 09/16/2004 | WO2004078731A1 Quinoline-carboxylic acids and the derivatives thereof, a focused library |
| 09/16/2004 | WO2004078729A1 Process for the production of substituted nicotinic acid esters |
| 09/16/2004 | WO2004078479A2 Imaging system |
| 09/16/2004 | WO2004078128A2 Substituted pyridine derivatives useful in the treatment of cancer and other disorders |
| 09/16/2004 | WO2004078109A2 PROCESS FOR SYNTHESISING USEFUL INTERMEDIATES FOR THE PREPARATION OF ανβ3 RECEPTOR ANTAGONISTS |
| 09/16/2004 | WO2004078103A2 G-lactam derivatives as prostaglandin agonists |
| 09/16/2004 | WO2004078030A2 Rhodol derivatives useful as image dyes |
| 09/16/2004 | WO2004064972A9 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 09/16/2004 | WO2004062562A3 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 09/16/2004 | WO2004050653A3 Oxime ester photoinitiators with heteroaromatic groups |
| 09/16/2004 | WO2004047739A3 Pyridinyl, pyrimidinyl and pyrazinyl amides as potassium channel openers |
| 09/16/2004 | WO2004046101A3 Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors |
| 09/16/2004 | WO2004043389B1 Methods of treating cancer and related methods |
| 09/16/2004 | WO2004028459A3 Piperidine derivatives |
| 09/16/2004 | WO2004026264A3 Novel aromatic compounds possessing antifungal or antibacterial activity |
| 09/16/2004 | WO2004004632A3 Flavone derivatives as inhibitors of cyclin-dependent kinases |
| 09/16/2004 | WO2003028729A3 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 09/16/2004 | US20040181068 and ras protein farnesylation; anti-cancer agents; also act as inhibitors of other prenyl transferases |
| 09/16/2004 | US20040181067 Tri(cyclo) substituted amide compounds |
| 09/16/2004 | US20040181062 Benzimidazole cyclooxygenase-2 inhibitor |
| 09/16/2004 | US20040180947 Sulfonamide compounds and pharmaceutical use thereof |
| 09/16/2004 | US20040180936 having an inhibitory activity on calpains and/or a trapping activity on reactive oxygen species; inflammatory and immunological diseases; disorders of the central or peripheral nervous system |
| 09/16/2004 | US20040180927 Inhibitors of cysteine protease |
| 09/16/2004 | US20040180912 for promoting the release of parathyroid hormone, e.g. for preventing or treating bone conditions which are associated with increased calcium depletion or resorption or in which stimulation of bone formation and calcium fixation in the bone is desirable |
| 09/16/2004 | US20040180910 Heterocycle carboxamides as antiviral agents |
| 09/16/2004 | US20040180905 for treating cancer and fibrotic diseases |
| 09/16/2004 | US20040180901 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 09/16/2004 | US20040180899 tyrosine kinase inhibitors |
| 09/16/2004 | US20040180896 P38 inhibitors and methods of use thereof |
| 09/16/2004 | US20040180894 Benzamide inhibitors of the P2X7 receptor |
| 09/16/2004 | US20040180891 Pyrazole derivatives useful in the treatment of hyper-proliferative disorders |
| 09/16/2004 | US20040180887 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 09/16/2004 | US20040180885 Indole derivatives, process for preparation of the same and use thereof |
| 09/16/2004 | US20040180882 Small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 09/16/2004 | US20040180863 Novel, nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
| 09/16/2004 | US20040180861 Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| 09/16/2004 | US20040180860 Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| 09/16/2004 | CA2517844A1 Quinazolines useful as modulators of ion channels |
| 09/16/2004 | CA2517422A1 Tetrahydropyran compounds as tachykinin antagonists |
| 09/16/2004 | CA2517088A1 Biaryltetrahydroisoquinoline piperidines as selective mch receptor antagonists for the treatment of obesity and related disorders |
| 09/16/2004 | CA2516931A1 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders |
| 09/16/2004 | CA2513652A1 G-lactam derivatives as prostaglandin agonists |
| 09/16/2004 | CA2512280A1 Benzofuran derivative |
| 09/16/2004 | CA2512243A1 N-aryl heteroaromatic products, compositions containing same and use thereof |
| 09/15/2004 | EP1457490A1 5-membered N-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 09/15/2004 | EP1457488A1 Intermediates for use in the preparation of urea compounds having muscarinic receptor antagonist activity |
| 09/15/2004 | EP1456657A1 Tagged microparticle compositions and methods |
| 09/15/2004 | EP1456207A2 Heterocyclic acridone inhibitors of impdh enzyme |
| 09/15/2004 | EP1456205A1 Imidazoquinoline derivatives |
| 09/15/2004 | EP1456200A1 Lactams as tachykinin antagonists |